Trials / Recruiting
RecruitingNCT07055984
Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- University Hospital, Martin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to improve the prediction and early detection of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients. The investigators are investigating whether specific microRNA profiles measured 3 months after transplantation can reliably predict the development of PTDM within the following one to two years. Additionally, the investigators are evaluating how traditional risk factors-such as age, immunosuppressive therapy, obesity, and infections like CMV-interact with these microRNA markers. The ultimate goal of this research is to identify early indicators of blood sugar issues, enabling timely interventions to improve health outcomes and personalize patient care after kidney transplantation.
Conditions
Timeline
- Start date
- 2025-04-28
- Primary completion
- 2028-04-28
- Completion
- 2029-04-28
- First posted
- 2025-07-09
- Last updated
- 2025-07-09
Locations
2 sites across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT07055984. Inclusion in this directory is not an endorsement.